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Agrin is a basement membrane protein crucial for development and maintenance of the neuromuscular junction in
vertebrates. The C. elegans genome harbors a putative agrin gene agr-1. We have cloned the corresponding cDNA to
determine the primary structure of the protein and expressed its recombinant fragments to raise specific antibodies. The
domain organization of AGR-1 is very similar to the vertebrate orthologues. C. elegans agrin contains a signal sequence for
secretion, seven follistatin domains, three EGF-like repeats and two laminin G domains. AGR-1 loss of function mutants did not
exhibit any overt phenotypes and did not acquire resistance to the acetylcholine receptor agonist levamisole. Furthermore,
crossing them with various mutants for components of the dystrophin-glycoprotein complex with impaired muscle function
did not lead to an aggravation of the phenotypes. Promoter-GFP translational fusion as well as immunostaining of worms
revealed expression of agrin in buccal epithelium and the protein deposition in the basal lamina of the pharynx. Furthermore,
dorsal and ventral IL1 head neurons and distal tip cells of the gonad arms are sources of agrin production, but no expression
was detectable in body muscles or in the motoneurons innervating them. Recombinant worm AGR-1 fragment is able to cluster
vertebrate dystroglycan in cultured cells, implying a conservation of this interaction, but since neither of these proteins is
expressed in muscle of C. elegans, this interaction may be required in different tissues. The connections between muscle cells
and the basement membrane, as well as neuromuscular junctions, are structurally distinct between vertebrates and
nematodes.
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INTRODUCTION
Agrin is a large proteoglycan with a prominent function at the
developing neuromuscular junction (NMJ) where it plays a pivotal
role in the formation and maintenance of the acetylcholine
receptor (AChR) clusters. Agrin was discovered more than two
decades ago through the observation that trophic factors from the
basal lamina extract of electric ray (Torpedo californica) were able to
induce AChRs clustering on muscles in vitro [1]. The protein was
subsequently purified from the extract of the synapse rich Torpedo
electric organ and, based on the observed aggregating activity, was
named ‘‘agrin’’, coming from Greek ‘‘ageirein’’ which means ‘‘to
assemble’’ [2]. Further studies revealed that agrin is synthesized by
motor neurons that release it into the synaptic cleft where it stably
integrates into the synaptic basal lamina (BL), a specialized thin
layer of the extracellular matrix (ECM) [3–5]. Based on these
findings, McMahan proposed the ‘agrin hypothesis’ which states
that agrin is a nerve-derived synaptic organizing molecule [6]
(reviewed in [7,8]).
Agrin has been cloned from several vertebrate species including
rat [9], chick [10,11], marine ray (Torpedo californica) [12] and man
[13]. All described agrin gene orthologues encode a large protein
of more than 2000 amino acids with an approximate molecular
weight of 225 kDa. Additional O-linked glycosylation by heparan
and chondroitin sulphate glycosaminoglycan chains, together with
N-linked carbohydrates, raise the molecular weight up to 400–
600 kDa [14,15] (reviewed in [8]). The domain architecture of
agrin is characterized by several repeated structural motifs which
share homology with follistatin (Kazal-type protease inhibitors),
laminin epidermal growth factor (EGF) and laminin globular
(lamG) domains. In addition, the protein contains a SEA module
(common between sea urchin sperm protein, enterokinase and
agrin) flanked by serine/threonine (S/T)-rich regions [9,10].
Differential transcription of the first exon results in a longer form
which is secreted and binds to the basal lamina via its laminin-
binding N-terminal agrin (NtA) domain [11,16,17] and a shorter
isoform which lacks the NtA domain and remains in the
membrane as a type II transmembrane protein [18,19]. Additional
alternative splicing, in a tissue-specific manner at two conserved
sites, termed A and B in chicken or y and z in rat, gives rise to
isoforms with significantly different activities in clustering AChRs
[20–22]. Isoforms expressed by motoneurons, which contain
inserts at the B/z splice site, are active in AChR clustering,
whereas agrin expressed by muscle lacks the inserts and does not
cluster AChRs.
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Despite of numerous studies available, the mechanism of agrin
action has not been completely resolved yet. Muscle specific kinase
(MuSK) is a transmembrane receptor tyrosine kinase necessary for
agrin-induced AChR clustering without direct interaction with
agrin. The missing link in this signaling pathway is a hypothetical
protein termed MASC (myotube-associated specificity component)
able to mediate the interaction between agrin and MuSK [23,24].
Genetic analysis of agrin and MuSK deficient mice support the
common function in AChR clustering [24,25]. Both mutants die at
birth due to breathing failure. Agrin loss of function mutants and
mice lacking only z+ agrin exons have a significantly reduced
number, size, and density of AChRs clusters on the muscle, even
though some postsynaptic differentiation is present [24,26]. In
MuSK mutant mice, NMJ synapses and the related specializations
can be found neither on the postsynaptic membrane nor in the
basal lamina [25]. Signaling downstream of MuSK is still largely
unclear. Several reports demonstrated MuSK-related activation of
different proteins, leading to AChR clustering. Among them were
dishevelled (Dvl), a protein involved in planar cell polarity
signaling [27], a cytoplasmic protein Dok-7 [28], and protein
casein kinase 2 (CK2) [29], essential for NMJ synaptogenesis in
vitro and in vivo.
In addition to the NMJ, many non-neuronal tissues such as
muscle, heart and kidney, express an agrin isoform without inserts
at the B/z site [20,30]. Alpha-dystroglycan (a-DG) binds to this
alternative splice variant in different tissues with strong affinity,
through a carbohydrate-dependent mechanism [31,32]. In
vertebrates, muscle dystroglycan is a central component of a large
dystrophin-glycoprotein complex (DGC) connecting the ECM
with the intracellular cytoskeleton (reviewed in [33,34]). Genetic
studies on animal models have shown that mutations in many
components of the DGC independently lead to the outcome of
muscular dystrophies (reviewed in [35–37]). Agrin binding to a-
DG might contribute to the connection between the ECM and the
cytoskeleton thus improving tissue integrity [38]. The interaction
between agrin and a-DG is functionally conserved in the
formation of the immunological synapse between antigen
presenting cells (APCs) and T-cells [39,40].
The nematode C. elegans is a useful model organism with many
experimental advantages, e.g. short generation time, easy
maintenance, transparent body and simple but specialized organs
which make it a powerful tool for genetic analysis [41,42]. C. elegans
harbors a gastrointestinal tract, a reproductive system, epithelial,
neural, muscle, excretory cells, and even innate immunity
pathways [43]. In addition, most of the molecular mechanisms
underlying major physiological processes are highly conserved
when compared to vertebrates [42]. Therefore, the experimental
data obtained from the worm proved to be highly informative and
applicable in elucidating many analogous mechanisms in mam-
mals (for a review, see [44]).
NMJs in C. elegans have some distinct morphological features
when compared to the vertebrate counterparts. Instead of having
motoneurons which grow axons towards the muscles they
innervate, muscles in C. elegans make specialized cell projections
called muscle arms, which extend from the muscle bundles to
reach the proximal nerve cord [45,46]. At the sites of contact, the
muscle arms make en passant synapses to the motor axons that run
along the anterioposterior axis. Depending on the type of the
neurotransmitter, the NMJ synapses can be excitatory (cholinergic)
or inhibitory (GABAergic). Genetic screens for synaptogenesis
mutants have identified key players in NMJ formation and
structure. Animals carrying mutations in synaptic components
often exhibit uncoordinated movements (unc), egg-laying defects
(egl), defecation defects or paralysis. Pharmacological assays with
nematocidal drugs, such as the cholinergic agonist levamisole or
the acetylcholine esterase inhibitor aldicarb, have been extensively
used in screening for mutants that are resistant to these drugs [41].
The genes for several postsynaptic AChR subunits were identified
on the basis of the resistance to levamisole, e.g. unc-29, unc-38, unc-
63, lev-1 [41,47]. Neuromuscular junctions in C. elegans are highly
dynamic structures. Several proteins have been identified as
crucial factors for normal NMJ development. One of them is
a transmembrane protein LEV-10. The mutant was identified as
weakly resistant to levamisole due to significantly reduced
postsynaptic density of AChRs [48]. Interestingly, the LEV-10
extracellular protein domain alone is sufficient to rescue the
lev-10 mutant phenotype, suggesting a novel AChR clustering
mechanism.
In vertebrates one of the key factors involved in AChR
clustering is the receptor tyrosine kinase MuSK. The gene with
the highest similarity to MuSK in C. elegans is an orphan receptor
KIN-8 (CAM-1) [49,50]. In addition to the impairment in cell
polarity and neuron migration, the kin-8/cam-1 mutants are
uncoordinated and have mislocalized AChR subunit ACR-16
[51]. Therefore, KIN-8/CAM-1 in C. elegans might be a protein
with a role similar to MuSK in vertebrates. Several other synaptic
ECM proteins have been implicated in the NMJ formation in the
worm, namely collagen XVIII (CLE-1) and nidogen (NID-1) [52].
Single mutants in each of the genes exhibit reduced numbers of
the enlarged and diffuse postsynaptic receptor clusters.
Different genetic approaches have been taken to investigate the
functions of the vertebrate gene homologues identified in the C.
elegans genome (reverse genetics) or to identify the previously
unknown genes which, if mutated in the worm, result in interesting
phenotypes (forward genetics). In reverse genetic approaches, the
goal is to learn more about a particular gene of interest and
address its mechanisms of action in C. elegans [53]. Since in C.
elegans and C. briggsae, two closely related nematode worm species,
putative agrin orthologues have been identified on the basis of
genomic sequence analysis [54], we decided to take a reverse
genetics approach to clone the C. elegans agrin cDNA, characterize
the protein, and describe its expression pattern. We found
expression of agrin in four head neurons, in the distal tip cell of
the gonad, and in epithelial cells of the pharynx. We could not
detect any agrin in muscle or at NMJs and genetic analysis of agrin
mutants did not provide any evidence for a major function of agrin
in AChR clustering or muscle function in the worm. However, the
known binding of agrin to a-DG in vertebrates seems to be
conserved in C. elegans, pointing to an ancestral role of this
interaction.
RESULTS
C. elegans expresses an agrin-like gene agr-1
A nematode agrin gene, with sequence homology to vertebrate
agrin, was identified in the C. elegans genome. The analysis was
based on queries by BLAST searches of Wormpep followed by
reciprocal BLAST searches of insect or mammalian orthologs in
GenBank [54]. In WormBase, the online database of the C. elegans
genome, the agrin gene was mapped to the cosmid F41G3,
originally as two separate open reading frames (ORFs) named
F41G3.12 and F41G3.15, corresponding to the 59 and the other to
the 39 part of vertebrate agrin, respectively. Based on the predicted
gene sequences, the agrin-specific primers (Table 1; Fig. 1) were
used to amplify overlapping fragments of each of the predicted
ORFs and of a putative common transcript from cDNA reverse
transcribed from RNA isolated from mixed stages of worms. As
a result, three overlapping fragments gave rise to one unique agrin
Agrin in C. elegans
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sequence instead of the two ORFs predicted by WormBase. The
incorrect prediction was probably due to three sequence mistakes
present in WormBase which resulted in false stop codons. The
additional bases identified in our cDNAs are highlighted with red
rectangles in Fig. 1 and their positions in the genome are indicated
by black arrows in Fig. 2. In WormBase release WS170 a single
agrin transcript of 1483 aa is predicted that shares 88% identity
with our experimentally determined sequence. Due to the above
mentioned nucleotide omissions in the genomic sequence as well
as several incorrect splice site predictions the WormBase protein
differs from ours in six locations. The identified agr-1 coding region
is 4422 bp long, with 59 and 39 untranslated regions of 212 and
160 bp, respectively (Fig. 1; EMBL/GeneBank Accession
AM773423). The agrin ORF is encoded by 29 exons which span
a chromosomal region of almost 14.5 kb (Fig. 2). The gene harbors
two very big introns, one following exon 4 and the other following
exon 24, but no alternative splicing was found. We attempted to
identify putative alternative exons corresponding to the B+/z+
splicing variants described in vertebrates [20,22] by performing
PCR with primers on neighboring exons, but could not detect any.
AGR-1 protein domain architecture is similar but not
identical to its vertebrate homologues
The predicted protein sequence of agrin (AGR-1) consists of 1474
amino acids (Fig. 1). Domains were predicted by computational
analysis of this protein sequence using the SMART bioinformatics
tool package (Fig. 3) [55]. A putative signal sequence of 22 amino
acids (purple) is followed by seven Follistatin domains (F, blue), two
epidermal growth factor domains of the laminin-type (LE, gray),
another follistatin domain (F, blue), an epidermal growth factor
(EGF)-like domain (EG, orange) and two laminin G domains
(LamG, yellow).
When compared to the known vertebrate agrin orthologues, the
C. elegans protein shares a high similarity in terms of modular
architecture, but is missing certain domains (Fig. 3). Vertebrate
agrin molecules exist in two different forms, one with a signal
sequence followed by a laminin-binding NtA domain (Fig. 3, light
purple) and another one with a non-cleaved signal sequence (TM,
empty rectangle) serving as a transmembrane anchor [11,18].
Using a 59 RACE approach in C. elegans only one isoform was
found, containing a signal sequence but no laminin-binding NtA
domain. The signal sequence, together with a corresponding
cleavage site between the amino acids 22 and 23, was predicted
with 0.74 probability by Signal P3.0 Server [56]. However, we
could not find any potential exon encoding a domain similar to the
NtA domain in the genomic sequence. The N-terminal part of
AGR-1 has seven repetitive follistatin domains, while vertebrate
agrin contains eight of them. Further differences are present in the
C-terminal part of the AGR-1 protein where the serine/theonine-
rich regions (S/T, light yellow) as well as the SEA (sea urchin
sperm protein, enterokinase, agrin) domain are missing. Verte-
brate agrin is a heavily glycosylated protein carrying large O-
linked heparan sulphate and chondroitin sulphate chains at several
positions in the protein [14,15] shown as branched structures in
Fig. 3. This is probably not the case for AGR-1 since the S/T-rich
region is missing. Finally, vertebrate agrins have three laminin G
domains (lam G), while AGR-1 has only two and no EGF-like
domains separating them. The overall similarities of the different
agrin segments to the corresponding regions of chicken agrin are
indicated in Fig. 3.
When the LamG domains from the C. elegans protein were used
as a query against Swissprot, Trembl and Refseq databases the
best hits besides the C. briggsae predicted agrin homologue
(Q61GM7_CAEBR) included vertebrate agrins as well as laminins
themselves and perlecans, shown in the alignments of Fig. 4A and
4B. In addition, a reciprocal analysis was done to see if some
vertebrate agrin lamG domains produce best similarity hits with
the nematode one. It turned out that the LamG domains of C.
elegans agrin are quite distinct from those in vertebrates, and that
the most similar lamG domains in vertebrates do not produce
clear reciprocal best hits. This is not surprising since the LamG
domains of the different proteins revealed equal similiarites to C.
elegans agrin LamG domains (Fig. 4A,B). However, blast searches
with each AGR-1 LamG separately resulted in a better match
between the first C. elegans lamG and the second LamG from
several vertebrate homologues, as well as between the second C.
elegans LamG and the third LamG domain of vertebrate agrins
(Fig. 4A and B). This implies that the two LamG domains of C.
elegans agrin rather correspond to the last two LamG domains of
vertebrate agrin. This is further supported by the alignment of the
region preceding the second LamG domain of AGR-1, which
aligned best to the chicken B0 agrin isoform, i.e. it does not contain
any inserts at the conserved B/z site (Fig. 4C). Based on the overall
domain architecture and the fact that agr-1 is the only gene in the
C. elegans genome to encode a protein of this unique domain
composition we conclude that AGR-1 is the nematode agrin
orthologue and not an orthologue of any other lamG domain-
containing protein.
Table 1. Primer sequences.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Primer name Sequence (59R39 direction)
agr 1 TGATGAAGCTGGAAGTCCCTGTGAG
agr 2 AATTCCCAGATGACTTTTCCAGCC
agr 3 ACGCGCATTGGCACCTTTCTC
agr 6 TGGGCATACACATTTGGGTTTTCCG
agr 9 GCCTCCATCTCATTGTCATTCATC
agr 12 TCGGATTGGCTCCTCCAAGATATAC
agr 25 GCAAGAAGGAGCATGGAGTCAG
agr/TN (antisense) GAAATTTCAGGCGCCATGGAGCAGTTGGGGCCTTTC
E32 AAGCATGCGGAGTTGAGTGGAGACGC
E33 AACTCTAGAGCGGCCGCAAGATCGATGTGAAGTCTCA-
TGTCGAC
E34 CACATCGATCCTCGTCCAACTCGTTCC
E35 TAGAGCGGCCGCTTCATTATCAAAAGTCTCTCC
E36 AAATCGATATGAGTAAAGGAGAAGAAC
E37 TTATCGATCTAGGCGCCTTTGTATAGTTCATCCATGCC
E149 TTGGTACCGCATGCCCGAGAGGAGTACGCGTCC
E150 TTGAGCTCAGTCGACTGCAGCATGGCGACATGTGAAA-
GTGAAAATG
lam 3 GAAGCATGCATGGCGCCTGAAATTTCAAGAAC
lam 6 GTGAAGCTTAGATATCAAATTGATTGGAAGT
lam 8 GTGAAGCTTTTAGTTATAGCAGTACTTGGGT
lam 8 euk 4 CAGCGGCCGCCATCTAGATTAGTTATAGCAGTACTTGGG
oligo dT (for 39UTR) GGCATGGTT(TTT)6
overlap59 agr (sense) ATGGCGCCTGAAATTTCAAG
T3 primer TTAATTGGGAGTGATTTCCC
XY1 GCCTGCAGTGTTATGAATTTTTCTTGAG
XY2 CCTCTAGATGAAAGTGAAAATGTTTCGTTTC
doi:10.1371/journal.pone.0000731.t001..
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Figure 1. C. elegans agrin DNA and protein sequence with predicted domain architecture. The C. elegans agrin coding sequence was assembled
from overlapping cDNA fragments, amplified by RT-PCR. The positions of the primers are shown by black arrows, where the corresponding pairs are
depicted with the same line pattern (full line, dotted line, ‘‘dash-dot-dash’’ line). The three nucleotides missing in the genomic sequence of the
database entry are framed with red rectangles. Based on the nucleotide numbering in cosmid F41G3, their positions are: C after 30028, A after 29776
and C after position 28351. The coding region of the gene is 4422 bp long with 59 and 39 untranslated regions of 212 and 160 bp, respectively (dark
gray boxes; EMBL/GeneBank Accession AM773423). The predicted protein sequence is 1473 amino acids long and the domain architecture is shown
in different colors. A putative signal sequence (purple box) is followed by seven follistatin domains (blue), two epidermal growth factor domains of
the laminin-type (light gray), a follistatin domain (blue), an EGF-like domain (orange) and two laminin G domains (yellow).
doi:10.1371/journal.pone.0000731.g001
Agrin in C. elegans
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Agr-1 is expressed in C. elegans buccal epithelium,
dorsal and ventral IL1 head neurons, and distal tip
cells of developing gonad, but not in body wall
muscles
To determine the expression pattern of the agr-1 gene, we made
different agr-1::reporter fusion constructs containing up to 5421 bp
upstream of the first exon and up to 3275 bp of sequence
downstream of the translational start codon including the large
intron after exon 4 (Fig. 5A). Another construct containing the gfp
gene flanked by agrin genomic sequences was co-injected with the
cosmid F09G5. For all five constructs 5–10 lines were isolated and
all of them exhibited GFP expression in the same patterns. Thus
inclusion of 1048 bp upstream of the transcription start seem to
harbor all regulatory sequences required to direct the highly
distinctive expression during development and in the adult worm.
Fluorescence started to be visible in two cells of young embryos at
around the 64 AB cell stage (Fig. 5B). Towards the end of
gastrulation expression was visible in about 40 cells throughout the
embryo including neuronal precursors, ventral hypodermal cells,
and pharyngeal precursor cells (Fig. 5C). At the 1 K to 2 fold
stages fluorescence was observed in IL1 neurons (the identity was
determined post-embryonically, see below), the nine buccal
epidermal cells, and additional cells in the head, most likely
arcade cells (Fig. 5D). Transient expression was also observed in
embryonic motoneurons (no longer visible in 3 fold stage embryos)
and in a few apoptotic cells in the head. Based on their position
Figure 2. Genomic organization of the agr-1 gene and mutant alleles. The assembled transcript consists of 29 exons which span over almost
14.5 kb on chromosome 2. Black arrows indicate the three locations where a nucleotide is missing in the database genomic sequence (exons 14, 15
and 20; cf. Fig. 1). Three mutations in the agrin gene were isolated. In the eg1770 mutant strain (black arrowhead) Mos1 transposon was inserted into
the seventh exon which results in an out-of-frame transcript, therefore causing a putative strong loss of function mutation. The eg153 strain (asterisk)
was created by imprecise excision of the Mos1 transposon leaving 5 bp at the insertion site and resulting in a +2 frameshift mutation. Mutant tm2051
(dotted line) carries a deletion of 423 bp including exons 26 and 27 resulting in an in-frame loss of 42 amino acids.
doi:10.1371/journal.pone.0000731.g002
Figure 3. Domain architecture of the C. elegans agrin protein in comparison to the vertebrate orthologues. C. elegans agrin starts with a signal
sequence (SS; purple), followed by seven follistatin-like domains (F; blue), two epidermal growth factor (EGF) domains of the laminin-type (LE; gray),
one follistatin-like domain (F; blue), an EGF-like domain (EG; orange), and two laminin G domains at the C terminus (LamG; yellow). The color scheme
follows the same pattern as presented in the Fig. 1. Predicted N-glycosylation sites are shown with blue circles. Vertebrate agrins have two alternative
N-termini: a secreted form, with a signal sequence (SS; dark purple) and a laminin-binding N-terminal agrin domain (NtA; light purple). These are
followed by follistatin domains, including one more than in C. elegans (F; blue), a sea urchin sperm protein, enterokinase and agrin domain (SEA; light
blue), two serine/threonine rich regions (S/T; light orange), and three laminin G domains (LamG; yellow). O-linked heparan sulphate and chondroitin
sulphate chains are schematically shown as branches and several N-linked glycoslation sites as blue circles. Alternative splicing at the last two LamG
domains of vertebrate agrin (A/y and B/z) gives rise to several agrin isoforms with different functions, but no alternative splicing was found in C.
elegans agrin. Three separate segments of C. elegans agrin marked by dashed lines were used in a Blast search. The resulting degrees of identity/
similarity to the corresponding parts of chicken agrin (Swissprot entry P31696-2) are indicated. Recombinant fragments 1 and 2 of C. elegans agrin
indicated above the LamG domains were used as antigens for raising monoclonal and polyclonal antibodies, respectively.
doi:10.1371/journal.pone.0000731.g003
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Figure 4. Alignment of the C. elegans lamG domains to the corresponding domains of other proteins. A, The first LamG domain of the C. elegans
protein (Agrin_LamG1_C.elegans) was used as a query for Swissprot, Trembl and Refseq databases. After the analysis of an extensive alignment, the
best hits were selected for this representation and include: the predicted agrin orthologue of C. briggsae (Agrin_LamG1_C.briggsae), the agrin LamG2
domains of the human, electric ray and chicken proteins, the LamG2 and LamG1 of human perlecan and the LamG4 of a laminin-like protein 2
(LAML2) identified in C. elegans. The similarities between each of the sequences compared to the C. elegans lamG1 are expressed as % identity/%
similarity. B, The second LamG domain of the C. elegans protein (Agrin_LamG2_C.elegans) was used as a query for Swissprot, Trembl and Refseq
databases. After the analysis of a more extensive alignment, the best hits were selected for this representation and include: the predicted agrin
orthologue of C. briggsae (Agrin_LamG2_C. briggsae), the LamG4 of human lamininA4, the LamG3 of human perlecan and the agrin LamG3 domains
of the human, electric ray and chicken proteins. The similarities between each of the sequences compared to the C. elegans lamG1 are expressed as %
identity/% similarity. C, The C. elegans agrin sequence aligns best with the B0/z0 isoforms of chick and rat agrin, respectively. The conserved
alternatively spliced agrin exons, encoding 8 aa, 11 aa or 19 aa inserts at this site, do not exist in C. elegans.
doi:10.1371/journal.pone.0000731.g004
Agrin in C. elegans
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they could be the sister cells of some of the IL1 neurons, which are
known to undergo programmed cell death at this developmental
stage (Fig. 5D). At the 3 fold stage expression was restricted to the
buccal epidermal cells, most of the arcade cells (3 anterior and the
DL and DR posterior arcade cells), and the six IL1 neurons
(Fig. 5E). The two lateral IL1 neurons expressed the marker only
weakly also in the L1 larval stage (but not later during
development) (Fig 5 F and I), whereas the dorsal and ventral
IL1 neurons expressed GFP strongly throughout all larval stages
and in the adults (Fig. 5 F–I). Starting from the L1 larval stage
Figure 5. Agr-1::reporter expression in transgenic animals. A, Reporter genes were fused to different portions of agrin non-coding and coding
sequences as shown in the schematic representation of the genomic region containing the agr-1 promoter and agr-1 59-end. The lengths of the
promoter or gene sequences and the names of the the pagr-1::reporter plasmids and DNA arrays are indicated. Since all of these constructs resulted in
the same expression patterns, representative micrographs of the kdIs66 transgenic worms are shown in B–J. B Expression starts in 2 cells in the
anterior part of the embryo at around the 64 AB cell stage. C, Towards the end of gastrulation expression is seen in about 40 cells throughout the
embryo including neuronal precursors, several ventral hypodermal cells and pharyngeal precursor cells (ventral view). D At the 1 1/2 to 2 fold stage
expression is seen in IL1 neurons (identity determined postembryonically), embryonic motoneurons and a number of additional cells in the head,
most likely arcade cells and epithelial buccal cells in the pharynx, and in few apoptotic cells (marked by +). E, In the 3fold stage embryos expression is
seen in the IL1 neurons (6 neurons), most of the arcade cells (3 anterior arcade cells and the DL and DR posterior arcade cells) and the buccal
epithelial cells in the pharynx. The 2 lateral IL1 neurons express GFP only weakly and only in early larval stages, wheras the remaining 4 IL1 neurons
express GFP strongly throughout all larval stages. F (dorsal view) and I In L1 larvae expression is observed, in the buccal epithelial cells (dashed arrow),
in 3 anterior arcade cells and the DL and DR posterior arcade cells (arrowheads), and in IL1v and IL1d neurons (arrows) and posterior gut cells
(asterisk). In F, the worm was co-stained with DiI. G and H Head of a young adult worm; expression is visible in the buccal epithelial cells (dashed
arrows) and in the IL1v and IL1d neurons (arrows); open arrowheads point at the IL1 processes in the nerve ring. J, L2 larva; expression in the
migrating distal tip cells (arrows) and posterior gut (asterisk). Bars are 10mm.
doi:10.1371/journal.pone.0000731.g005
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expression could also be observed in the posterior cells of the gut
(Fig 5 I–J). Starting from the L2 stage, when gonad development
and migration begins, fluorescence became also visible in the distal
tip cells of the gonad (Fig. 5J).
To identify the four head-neurons expressing agr-1, we stained
amphid neurons with DiI in the hdEx25 transgenic lines, with or
without 50mMCaAcetate. We did not find any co-staining between
the red and yellow fluorescing dyes in these experiments, suggesting
that the four neurons were neither amphids, nor IL2 neurons
(Fig. 6A–F). We then analyzed agr-1::dsRED expression in the
kdEx71; otIs107(ser-2::gfp) [57] and in the kdEx71; adIs1240(eat-4::gfp)
[58] transgenic lines. No co-staining was observed in kdEx71; otIs107
(results not shown), suggesting that the neurons expressing agr-1 are
not the OLL neurons. In the kdEx71; adIs1240 animals the dorsal
and the ventral, but not the lateral IL1 neurons co-stained for the red
and green markers, allowing us to identify the agr-1 expressing
neurons as the dorsal and ventral IL1 neurons (Fig. 6G–I).
In vertebrates agrin plays an important role in synaptogenesis at
the neuromuscular junctions and in muscle stability (reviewed in
[8]), therefore we carefully looked whether agr-1 is expressed in
muscles and neurons of the nematode. We did not observe any
marker expression in muscles, and we observed a weak, transient
expression in motoneurons in the embryo, but not in larval nor
adult stages, implying that the gene is not expressed in these tissues
postembryonically or is expressed at undetectable levels.
Agr-1 does not interact genetically with genes
important for synaptogenesis and muscle stability in
the worm
To further investigate the putative involvement of agr-1 in
synaptogenesis and muscle stability, we tested potential genetic
interactions between agr-1 and factors involved in these processes
in the worm (summarized in Table 2). The agr-1(eg1770) single
mutant did not show any obvious phenotype and its movements
and co-ordination seemed normal. We tested the sensitivity to
aldicarb and levamisole of the agr-1(eg1770) single mutant and in
the lev-1(e211) [59] and dys-1(cx18); dyb-1(cx36) [60,61] back-
grounds. The eg1770 mutation did not influence cholinergic
activity in these backgrounds suggesting that the agr-1 gene does
not play a role in the biogenesis and activity of cholinergic
synapses (data not shown).
In order to investigate possible genetic interactions of agr-1 with
components of the dystrophin-glycoprotein-complex (DGC) we
generated double and triple mutants between agr-1(eg1770) and
the following mutant strains: dystrophin dys-1(cx18), dystrobrevin
dyb-1(cx36), dys-1(cx18);dyb-1(cx36) [60,61], as well as with hlh-
1(cc561), previously shown to enhance the phenotypes of hypo-
morphic muscle mutants due to a mutation in the transcription
factor MyoD1 [62]. In addition, agr-1(eg1770) was crossed with
several mutants for components of the extracellular matrix, i.e.
perlecan unc-52(gk3), unc-52(e444) [63], collagen cle-1(cg120) [64]
and nidogen nid-1(cg119) [65], and with a mutant affecting the cell
adhesion factor dig-1(n1321) [66]. The single, double, and triple
Table 2. Different genetically sensitized backgrounds did not
reveal a function for agr-1.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
agr-1 locus comparison genetic background phenotypes tested
eg1770 vs. WT WT a, b, c, d, e, f, n, h, s
lev-1(e211) a, b, c, d
dys-1(cx18) a, b, c, d, g
dys-1(cx18) a, b, c, d, g
dys-1(cx18); dyb-1(cx36) a, b, c, d
hlh-1(cc561) a*, b*, c*, d*, f*
unc-52(e444) a, h, i, r, d
unc-52(gk3) a, h,i, d
cle-1(cg120) a, b
nid-1(cg119) a, b
dig-1(n1321) a, b, p, q
eg153 vs.WT WT a, b, c, n, s
tm2051 vs. WT WT a, b, s
Agr-1 mutants were tested in different genetic backgrounds and the following
phenotypes were analyzed: a, locomotion; b, response to touch on head and
tail; c, sensitivity to levamisole; d, sensitivity to aldicarb; e, muscle integrity by
DIC; f, muscle integrity by rhodamine-phalloidin staining; g, muscle integrity
(myosin fibers) in worms expressing MYO-3::GFP (stEx30); h growth rate; i,
paralysis progression; m, brood size, n, thrashing assay; p, egg laying; q, gonad
displacement; r, gonad arm migration; s, pharynx pumping-rate in feeding
worms. *, tested at 15uC and at 20uC.
doi:10.1371/journal.pone.0000731.t002..
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Figure 6. Agr-1 expression in IL1d and IL1v neurons. A–C, DiI staining in hdEx25 trangenic worms; no co-staining is observed between agr-1::YFP (A)
and DiI (B). In D–F, no costaining is observed between agr-1::GFP (D) and DiI+CaAcetate (E) in kdIs66 transgenic animals. In G–I, costaining is observed
in eat-4::GFP (G) and agr-1::dsRED (H) in adIs1240; kdEx71 transgenic worms. Figures C, F, I show merged channels. In all panels dashed arrows point
out dendrites; arrows point to neuronal cell bodies; arrowheads mark buccal epithelial cells and asterisks indicate the nerve ring.
doi:10.1371/journal.pone.0000731.g006
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mutant strains were scored for locomotion in normal conditions or
under stress, in thrashing assays, response to touch, and viability.
In addition muscle integrity was assessed by visualizing the muscle
fibers either with rhodamine-phalloidin staining [67] or with the
stEx30(myo-3::gfp) array [68]. The agr-1(eg1770) mutation did not
aggravate any of the phenotypes of the different mutant
backgrounds, suggesting that agr-1 function is dispensable in the
muscles of the worm (Table 2).
Specific monoclonal and polyclonal antibodies
detect agrin in the basement membrane of the
pharynx
To confirm the agrin expression pattern at the protein level and to
obtain more information on its possible function in the nematode,
we raised specific antibodies against the lamG domains (Fig. 7A).
The first lamG domain was expressed in E. coli, purified and used
as antigen to raise monoclonal antibodies. A fragment containing
both lamG domains was fused to a short sequence of chicken
tenascin-C (Tn-C), expressed in HEK293EBNA cells, purified
from the conditioned media and used to raise polyclonal
antibodies. The specificity of both polyclonal and monoclonal
antibodies was tested by western blotting and immunostaining of
COS cells transiently transfected with the TN-C-agrin fusion
construct (Fig. 7). In the conditioned medium, a band of around
80 kDa, which corresponds to the size of the recombinant protein,
was detected by all antibodies. The polyclonal serum recognized
additional smaller fragments which probably correspond to
protein degradation products. Transfected and non-transfected
cells were stained with the anti-agrin monoclonal antibody pool
Figure 7. Antibodies against C. elegans agrin. A, Schematic representation of the recombinant fragments used as antigen to raise monoclonal and
polyclonal antibodies. For eukaryotic expression the C-terminal lamG domains were fused to a short fragment of chicken tenascin C (Tn-C), including
a secretion signal and the epitope of the anti-Tn60 antibody. The specificity of both polyclonal and monoclonal antibodies was tested by western
blotting on conditioned medium of COS cells transfected with the construct encoding the two LamG domains with the Tn-C-tag (B). Lanes 1 and 2
were incubated with polyclonal antisera from two different rabbits, lane 3 with the monoclonal antibody pool raised against the bacterially expressed
fragment, and lane 4 with pre-immune serum. All antibodies detected a band of about 80 kDa, which corresponds to the size of the recombinant
protein. Additional smaller bands (asterisk) most likely correspond to degradation products which are not recognized by the monoclonal antibodies.
C–J, Immunofluorescence staining of transfected COS cells was performed with the anti-agrin monoclonal antibody pool (C–F) and compared to the
anti-Tn60 control (G–J). In transfected cells (C and D; G and H) the secreted agrin fragment was detected on cell surfaces of non-permeabilized cells
(C and G) or in the endoplasmatic reticulum/Golgi apparatus of permeabilized cells (D and H). Non-transfected cells were used as a negative control
(E and F; I and J).
doi:10.1371/journal.pone.0000731.g007
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(Fig. 7C–F) as well as the monoclonal antibody against the TN-C
epitope tag (Fig. 7G–J). In the permeabilized cells (Fig. 7D and H),
the overexpressed fragment could be detected mainly in the Golgi
apparatus while in non-permeabilized cells (Fig. 7C and G) the
agrin protein could be detected in patches bound to the plasma
membrane. This represented a first indication that COS cells may
express a surface receptor which binds agrin. Non-transfected
COS cells did not give any immunfluorescence signal (Fig. 7 E–J).
In order to detect the endogenous worm agrin protein, we
analyzed worm extracts by western blotting with purified anti-
agrin polyclonal antibodies. We compared extracts from wild type
worms with the three agrin mutants available, agr-1(eg1770), agr-
1(eg153) and agr-1(tm2051) described in Experimental procedures.
Extracts were prepared from about 50 ml of synchronized young
larval stages (L1 and L2). The fractions soluble in RIPA buffer
(including 6M urea) are presented in Fig. 8A. Two bands, one of
about 160 kDa and the other of about 75 kDa, were detected by
anti-agrin antibody in the lysate of wild type worms, but not in any
of the three agrin mutant strains. The 160 kDa band corresponds
to the calculated weight of the full length agrin protein, while the
smaller band could represent a degradation product. Two
additional bands (asterisks) which were present in all analyzed
strains seem to be due to a cross-reactivity with other unidentified
proteins.
To localize the agrin protein, the worms were co-stained with
the monoclonal antibody pool against C. elegans agrin and with
polyclonal anti-rim antibody, recognizing a pre-synaptic marker
prominent in the nerve ring [69]. The major site of agrin
expression was around the pharynx and the staining was
particularly enriched in the anterior part (Fig. 8B). The posterior
bulb was labeled more weakly correlating with the fainter GFP
reporter expression in the posterior part. Polyclonal antiserum
staining resulted in the same staining pattern in wild type worms of
different developmental stages (Fig. 8C and D). Young larvae (L1)
generally showed stronger agrin staining compared to young
adults (C compared to D, respectively). Pharyngeal staining was
absent in all three agrin mutant strains, which is an additional
confirmation for their lack of agrin expression (Fig. 8F–H). No
staining could be observed in body wall muscles, in the synapses
along the ventral and dorsal nerve cords, in the gonad and in the
posterior gut cells. In addition to the pharynx staining in the wild
type worms, the polyclonal antiserum stained the gut lumen
(arrowhead) both in the wild type worms as well as in the agrin
mutants, but not when preimmune serum was used. The staining
of the lumen of the gut represents an unrelated cross-reactivity of
our antiserum, possibly corresponding to the background bands
detected on the western blots.
The strong pharyngeal localization led us to suspect that agrin
has a pharynx-related function, namely in feeding behavior or
structural stability. Therefore, we investigated the pharyngeal
pumping rate of normal versus mutant animals, but could not
detect any differences. Despite the absence of agrin in the pharynx
of the mutants, pharyngeal morphology was normal in young as
well as in older animals (data not shown). To challenge the
pharynx function, we fed agrin mutants with different strains of
bacteria of various sizes [70]. However, even ingestion of the
largest bacteria, strain Bacillus megaterium, did not result in
a different growth rate as compared to the wild type animals.
Recombinant fragment of C. elegans agrin binds to
purified chicken a-dystroglycan
Based on the well described binding of agrin to a-dystrolgycan in
vertebrates [31,32], we addressed this possible interaction in the
case of C. elegans agrin. The interaction between agrin recombinant
fragment containing two lamG domains and dystroglycan was
tested biochemically by a protein overlay assay. Purified chicken
a-dystroglycan was run on an SDS-acrylamide gel and blotted to
a nitrocellulose membrane. Strips of this membrane were
incubated either with conditioned medium containing the
Figure 8. Detection of endogenous C. elegans agrin by western blot and immunofluorescence. Lysates of wild type (N2) and agrin mutant worms
(eg1770, eg153, tm2051) were analysed on western blots (A). Two prominent bands of about 160 kDa and 75 kDa were present exclusively in the wild
type (Wt) worms and not the mutants. The larger band corresponds to the calculated size of the full length AGR-1 protein and the smaller band may
represent an agrin degradation product. Asterisks denote two additional background bands present in all the strains. B, Worms were immunostained
with the monoclonal antibody pool against C. elegans agrin (green) and Rim, a synaptic marker prominent in nerve ring (red). Agrin was detected in
the basal lamina around the pharynx procorpus (arrow) and anterior bulb (asterisk). Posterior bulb staining was weaker possibly due to poor antibody
penetration (dashed arrow). (C–H) Polyclonal antiserum staining resulted in the same pattern in the pharynx of wild type worms (C and D, asterisk for
anterior bulb) whereas it was clearly absent in agrin mutants (F–H). Prominent background staining of the gut was present in all strains (C–H,
arrowhead). Preimmune serum of the same rabbit was used as negative control on wild type worms (E) where both pharyngeal and gut staining was
clearly missing.
doi:10.1371/journal.pone.0000731.g008
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recombinant C. elegans agrin fragment or with purified recombi-
nant chicken agrin fragments representing the muscle (A0B0) and
neuronal (A4B8) agrin isoforms. Following several wash steps, agrin
bound to a-DG was detected with anti-Tn60 antibodies that
recognize the short TnC part fused to agrin (Fig. 9). The chicken
muscle agrin fragment, which served as positive control bound
efficiently to dystroglycan, appearing as a dark smear caused by
the migration behaviour of the highly glycosylated distroglycan
(Fig. 9, lane 1), while the neuronal isoform gave a very weak signal
at the dystroglycan protein core size of approximately 200 kD
(lane 2). The C. elegans agrin fragment also bound to DG and was
detectable as a smear on the membrane strip similar to the chicken
muscle agrin (Fig. 9, lane 3). In parallel, a strip containing 50 mg of
proteins of crude COS cell lysate served as negative control for
unspecific binding of agrin to any blotted proteins (Fig. 9, lane 4).
Furthermore, dystroglycan containing strips incubated with
conditioned medium from non-transfected cells did not result in
a signal (lane 5). This indicates that C. elegans agrin harbors the
ability to specifically bind to a-dystroglycan.
C. elegans agrin induces endogenous dystroglycan
clustering in COS cells
The interaction between C. elegans agrin and DG was further
investigated in cell cultures of COS cells transfected with the
recombinant fragment of C. elegans agrin (fragment 2 in Fig. 3).
Transfected cells secreted the agrin fragment into the medium
where it bound to the cell surfaces of transfected as well as
untransfected cells in a patchy pattern (Fig. 10 A–C). Remarkably,
the dystroglycan staining followed the same pattern (Fig. 10 E–G)
and overlapped with the agrin staining in patches (Fig. I–K), while
the dystroglycan staining of untransfected cells showed a diffuse
and intracellular staining (Fig. 10 H). The anti-b-DG antibody
recognizes the intracellular part of the protein, therefore only
permeabilized cells show strong staining. Immunostaining experi-
ments with the pool of the monoclonal anti-agrin antibodies
resulted in the same pattern as with polyclonal antibodies (data not
shown), but co-staining with anti-b-DG was not possible due to the
same host species in which the antibodies were raised. Our results
suggest that the recombinant agrin fragment containing the two
lamG domains bound to the cell membrane, probably through
direct interaction with dystroglycan. Interestingly, the endogenous
dystroglycan had a diffuse pattern in cells without agrin over-
expression, but it appeared clustered by agrin secreted from the
transfected cells, suggesting that agrin bound to the cells and
induced clustering of DG.
DISCUSSION
We have identified and characterized the first invertebrate agrin.
In terms of domain structure, a high degree of similarity was found
between C. elegans and vertebrate agrins, although some domains
were missing. In the worm, only one N-terminal variant was
detectable containing a secretion signal but no NtA domain [11].
Several other domains were missing, namely the Ser/Thr-rich
region, the SEA module, and one of the three lamG domains at
the C-terminal end of the molecule. We analyzed the two lamG
domains present in the worm and compared them to the
vertebrate lamG domains to determine whether they corre-
sponded to a particular domain pair of vertebrate agrin. Blast
searches revealed that the AGR-1 LamG domains aligned best to
the last two LamG domains of vertebrate agrin. However, we
could not detect any small inserts known to be important for the
Figure 9. In vitro interaction between C. elegans agrin and
vertebrate a-dystroglycan. Purified chicken a-DG (lanes 1–3 and 5)
or crude COS cell extract (lane 4) was transferred to the membrane after
separation by SDS-PAGE and membrane strips were incubated with
different samples of agrin: lane 1, chicken muscle agrin isoform; lane 2,
chicken neuronal isoform; lanes 3 and 4, C. elegans agrin in conditioned
medium of transfected COS cells; lane 5, conditioned medium of non-
transfected COS cells. Binding of the respective agrins was detected by
anti-chick agrin antibody (lanes 1 and 2) or with the Tn60 antibody
recognizing the short tenascin C fragment which was fused to the C.
elegans agrin fragment (lanes 3, 4 and 5). Binding of C. elegans agrin to
a-DG was detected in lane 3, but not in the negative controls (lanes 4
and 5).
doi:10.1371/journal.pone.0000731.g009
Figure 10. Recombinant C. elegans agrin clusters endogenous
dystroglycan in COS cells. COS cells were transfected with the
recombinant fragment of C. elegans agrin and immunostained for agrin
and endogenous b-DG. A–D, agrin staining; E–F, anti-b-DG staining; I–L,
overlay including nuclear staining. A–C, In transfected cells, secreted
agrin bound to the cell surface in a patchy pattern to cells producing
large quantities of agrin (A) as well as to cells expressing little or no
agrin themselves (B, C). The cells were co-immunostained for
endogenous b-DG (E–H) which, in transfected cell cultures, colocalized
with agrin on cell surfaces. In non-transfected cells (D–L), no agrin
staining was present (D) and b-DG showed diffuse staining (H and L).
doi:10.1371/journal.pone.0000731.g010
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clustering function of the vertebrate neuronal agrins [20,21].
When we searched the intron sequences between the last few
exons encoding the LamG domains in all three frames, we could
not detect any potential alternative exons coding for amino acids
resembling the conserved inserts in the A/y and B/z sites of
vertebrates. Therefore, we concluded that in C. elegans there is only
one major agrin isoform expressed and that the A/y and B/z
alternative spice sites are specific to vertebrates.
With the goal to detect the endogenous agrin by western blot,
we raised polyclonal antibodies against the fragment comprising
two lamG domains. Purified antibodies detected protein bands of
about 160 kDa and 75 kDa, present only in the lysates of the wild
type worms and not in any of the agrin mutants. The bigger band
corresponds to the protein core size and the smaller possibly to
a degradation product or a shorter isoform. In the loss of function
mutants agr-1(eg1770) and agr-1(eg153) we expected a complete
lack of the protein, but agr-1(tm2051) carrying an in-frame deletion
and was expected to express a shorter protein. However, in the agr-
1(tm2051)mutant the deleted exons 26 and 27 encode the majority
of the region against which the polyclonal antibodies were raised.
Therefore, this truncated protein may not be recognized and no
band detected even though the protein may be expressed. Another
possibility is that the protein with the deletion does not fold
properly and gets degraded. In any case, it is clear that the agrin
mutants do not express the normal agrin protein as the wild type
worms do.
The most surprising result of our study was the fact that we
could not detect any agrin expression neither in body wall muscles
nor in motoneurons innervating them (except for a transient
expression in some embryonic motoneurons). The lack of agrin
expression at the NMJs suggested that agrin may not have
a conserved function in AChR clustering in the worm. Neverthe-
less, we investigated the possible phenotypes in C. elegans agr-1
mutants related to muscle and/or NMJ function. In the case of
defective muscle or NMJ formation, worms should display
uncoordinated (unc) movement, defective thrashing pattern, and/
or egg laying deficiency. However, we did not observe any
significant impairment neither in agr-1 single mutants, nor in
combination with other related mutations. Pharmacological assays
with levamisole, a potent nematode-specific cholinergic agonist
[47] and aldicarb, an ACh esterase inhibitor [71], did not reveal
any resistance in agr-1 mutants. Therefore, in C. elegans we could
not find any evidence for a role of agrin in muscle or synaptic
functions, suggesting that the ancestral function of Agrin was not
in NMJ formation. In accordance with our hypothesis, no clear
MuSK orthologue (the vertebrate receptor for agrin) has been
found in the nematode. Up to date only two factors important for
nicotinic AChR clustering have been characterized in the worm.
The Ror RTK Cam-1 is necessary for the localization of the ACR-
16 (nicotinic AChR a-subunit) at the NMJ, but no kinase activity is
needed for this function [51]. Another protein, essential for
clustering levamisole-sensitive AChR at the NMJ in the worm, is
LEV-10. Also for LEV-10, its extracellular domain was shown to
be sufficient for the clustering [48]. Interestingly, vertebrates
express proteins that share high similarity to CAM-1 and LEV-10,
suggesting that these novel factors discovered in the worm could
have been conserved during evolution. Thus, both CAM-1 and
LEV-10 may be components of distinct pathways important for
AChR clustering in nematodes that may have been complemented
by the agrin-MuSK pathway during evolution in vertebrates.
We then took a closer look at the sites of agrin expression
visualized by reporter genes and antibody staining. Prominent
expression was found in four head neurons and some pharyngeal
cells. This relatively restricted expression pattern was confirmed by
several reporter constructs with varying portions of the gene as
well as by antibody staining.
We identified the four agrin-expressing neurons by injecting agr-
1::dsRED construct into the transgenic lines expressing GFP in
specific neuron subtypes [58]. This approach identified the agrin-
expressing neurons as inner labial (IL1) sensilla polymodal
neurons. These are mechanosensory neurons, motoneurons and
interneurons at the same time [72]. There are six IL1 neurons in
total (three pairs) in the head of the worm [73], but agrin was
found to be expressed only in the dorsal and ventral pairs. Such
a sub-specialization might be significant to distinguish very fine
sensory inputs from the environment. It is known that IL1 neurons
together with OLQ (outer labial quadrant sensilla) neurons are
responsible for the sensing of a light nose touch and the regulation
of spontaneous foraging movements [72]. Therefore, we tested
agrin mutants for light nose-touch-avoidance by the eyelash test
[74]. Agrin mutants seemed to be as sensitive to touch as the wild
type worms, suggesting that absence of agrin does not lead to
a complete failure of IL1 function. Furthermore, IL1 neurons did
not show any morphological abnormalities in the agr-1(eg1770);
hdEx25 strain.
The pharyngeal cells expressing agrin belong to the buccal
epithelium which surrounds the anterior-most part of the
pharyngeal lumen ([75]; Wormatlas, http://www.wormatlas.org/
). In early larvae agrin is also expressed in other pharyngeal cells,
most likely the marginal cells. The epithelial tissue forms a rigid
narrow cylinder restricting the food entry into the pharynx [75].
Agrin expressed in this tissue might have a function in the
structural support of the pharynx. The immunostaining with
monoclonal and polyclonal anti-agrin antibodies detected the
protein around the pharynx, resembling perlecan immunostaining
in the pharynx basal lamina [76]. Thus, agrin is probably secreted
from the pharyngeal cells and integrated into the basal lamina.
This pharyngeal staining was missing in all three agrin mutant
strains. To test proper pharynx function we measured the
pumping rate, which did not differ between agrin mutants and
wild type worms. To challenge pharynx function more drastically
we tested whether bacterial size had any influence on the feeding
and ingestion capability of the worms. For that purpose we grew
the worms on Bacillus megatherium, a strain of large bacteria and
compared it to the E. coli OP50 strain used in regular laboratory
maintenance [70]. Pumping defective mutant strains eat-4(ky5) and
eat-5(ad464), which grow much more slowly on large bacteria,
were used as positive controls. On both food sources our agrin
mutant agr-1 (eg1770) grew equally fast as wild type worms.
Pharynx morphology and resistance to mechanical stress seemed
normal in the agr-1 (eg1770) mutant animals, suggesting that agrin
is not essential for proper development or structural support. If
agrin plays a role in pharynx-related functions, it is subtle or
redundant.
Some expression of agrin was present in the distal tip cells of
developing gonads in young larvae. The distal tip cell is critical for
germ line proliferation and guides gonad migration by sensing
environmental cues [77,78]. We have investigated a possible effect
of agrin deficiency in gonad migration or brood size, but the
mutants were indistinguishable from the wild type worms in these
aspects.
Interaction between agrin and a-dystroglycan in vertebrates is
important in different tissues and processes (reviewed in [8,79]). At
the NMJ, DG stabilizes mature synapses by connecting the basal
lamina to cortical F-actin. In the muscle sarcolemma DG is
a central component of a large dystrophin-glycoprotein complex
(DGC) where it serves again as a linker between the ECM and
intracellular cytoskeletal proteins (reviewed in [33,34]). At the
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NMJ and at the muscle membrane agrin binds with its C-terminal
lamG domains to a-DG and with its N-terminal part to laminin
providing additional support. Interaction between agrin and a-DG
is found as well in the immune system, where this binding mediates
lymphocyte activation via a lipid raft-dependent mechanism [40].
Based on the established knowledge on vertebrate agrin and DG,
we decided to investigate whether this interaction is conserved in
C. elegans. We could demonstrate direct binding of a recombinant
fragment of C. elegans agrin to purified vertebrate a-DG by
a membrane overlay assay. In COS cells transfected with the same
recombinant fragment, endogenous DG was clustered and
colocalized with agrin bound to the cell membrane.
Taken together, our experiments suggest that the interaction
between agrin and dystroglycan may be conserved in C. elegans but
this interaction does not play a role at the NMJ or in muscle in
general. This view is supported by the observation that C. elegans
dystroglycan, dgn-1, is not expressed in muscle either, but rather in
epithelia and neurons. It is found in basement membrane surfaces
and is not involved in muscle function [80]. Therefore, the
structural organization at the molecular level of the NMJ, as well
as the DGC complex, is clearly distinct in C. elegans as compared to
vertebrates. Our studies demonstrate that the existence of protein
orthologs in evolutionarily distant organisms [54] does not
necessarily imply identical functions, at least not in every aspect.
In C. elegans it appears that the muscle basal lamina depends rather
on the presence of the perlecan orthologue unc-52 [63,76,81,82]
and on the integrin chain orthologues pat-2 and pat-3 [83–86] and
not on dystroglycan and its ligands [80]. On the other hand
dystroglycan and agrin appear to function in epithelia and certain
neurons but not in muscle. Our results indicate that the ancestral
agrin function included dystroglycan binding but not AChR
clustering activity at NMJs, a feature acquired later during
evolution. Since also in vertebrates, agrin is expressed outside of
muscle and NMJs, C. elegans can be a good model organism to
delineate these ancestral functions of agrin that may still be
functional in vertebrates as well.
MATERIALS AND METHODS
C. elegans culture conditions and preparation for
RNA and protein extraction
The worm strains were grown at 20uC on NGM agar plates
seeded with E. coli OP50 [41]. For growth in large amounts and
further protein extraction, worms were grown at 20uC on 10 cm
culture dishes with NGM medium and the addition of egg yolk
[87]. In order to prepare synchronized cultures of young larvae,
gravid worms were washed with M9 buffer and subjected to
sucrose flotation [88], then bleached [89] followed by extensive
washing in M9. The larvae hatched and, when they reached the
L2 larval stage, were rinsed off the plates with M9 buffer, washed
in M9, deionized water, and quick-frozen in liquid nitrogen.
Sequence identification and cDNA cloning
Total RNA was isolated from a mixed-stage worm population
(Trizol reagent, Gibco) and reverse-transcribed into cDNA using
oligo dT primers and MMLV reverse transcriptase from
AdvantageTM RT-for-PCR Kit (Clontech) according to the
supplier’s protocol. Agrin cDNA was amplified by using sets of
primers designed according to the predicted gene sequences in the
Wormbase (ACeDB: F41G3.15 and F41G3.12, as of January 1,
2003; presently, only one common ORF exists in the database
under the name F41G3.12) in order to obtain overlapping PCR
products using the following primers: agr3 and agr6; agr1 and
agr2; agr9 and agr12; agr25 and oligo dT primers listed in Table 1.
In parallel, a commercial C. elegans cDNA libray (OriGene
Technologies) and the EST clone Yk1264e03 (vector pME18S-
FL13, kindly provided by Dr. Yuji Kohara) were used as
templates. The 59UTR was determined with 59RACE approach
(Roche) following the supplier’s protocol. Agrin cDNA sequence
was assembled from overlapping fragments resulting in an open
reading frame (ORF) of 4422 bp.
Protein architecture analysis and alignments with
vertebrate orthologues
Protein architecture was analysed with SMART (EMBL, [55]),
and with Blast at ExPASy [90]. Several overlapping domains were
predicted, but in this report only a representative structure is
presented based on the similarity to the vertebrate orthologues.
Laminin G domains of C. elegans agrin were used as a query in
myHits [91] against Swissprot, Trembl and Refseq. After the
analysis of a more extensive alignment, the most informative
Swissprot hits were selected. Visualization was done in Jalview,
using Zappo colors without conservation threshold, to analyze
subgroups [92]. Alignments were submitted to the Boxshade server
at Pasteur (http://bioweb.pasteur.fr/seqanal/interfaces/box-
shade.html) for producing the greyscale shading. Pairwise
comparison of sequences (% identity/% similarity) was performed
using Smith Waterman alignments (as implemented in water, a tool
in the EMBOSS package; [93]. The homology searches between
fragments of C. elegans agrin sequence and chicken agrin were done
at myHits (SIB) using iterative PSI-BLAST searches [91]. The C.
elegans fragment composed of 2 lamG domains yielded different
Blast scores for alternatively spliced chicken agrin isoforms
(Swissprot), which was due to the presence, or absence, of the
spliced exons. The alignments of the conserved alternative splicing
site were produced by Blast at ExPASy.
Agr-1::reporter expression constructs for expression
pattern analysis
Agrin fragments were cloned following standard procedures [94].
The constructs used to create transgenic animals were the following:
Pagr-1::dsRED (p251). A 1926 bp genomic DNA fragment
immediately upstream of the agr-1 ATG start codon was amplified
using the primers E149 and E150 (the sequences of the primers are
listed in Table 1). The SalI site near the start codon was removed by
introducing a point mutation in the sequence of primer E150 (bold
and underlined in Table 1). The PCR fragment was then cloned into
the SphI-SalI sites of the vector pVH14.05. The vector contained the
dsRED gene and was constructed by cloning dsRED into pVH20.01
via AgeI and MfeI (pDsRed2-N1)/EcoRI(pVH20.01) giving rise to
a promoterless vector with DsRed2 carrying Amp resistance.
Pagr-1::yfp (pVH11.07). A 1527 bp genomic DNA upstream of
the agr-1 ATG start codon was amplified with the primers XY1
and XY2 and cloned into the PstI-XbaI sites of pVH20.01
(promoterless yfp vector), kind gift for Prof. Harald Hutter.
PVH20.01 was constructed by replacement of the KpnI-SpeI
fragment in pPD95.75 by the same fragment from pPD132.102,
promotorless vector with YFP (gf42 A.Fire).
Pagr-1::gfp (5.5 Kb) (p130). A 5431 bp genomic DNA fragment
including 5421 bp of promoter sequence and the first 12bp of the
agr-1 ORF was amplified with the primers E32 and E33. The
fragment was then ligated into the SphI-XbaI sites of the pPD95.75
vector (Fire Lab vector kit). The NotI and ClaI sites introduced with
the primer E33 are needed for further cloning (see below).
Pagr-1::gfp (8.6 Kb) (p143). A 3198 bp genomic DNA fragment
from the 59 region of the agr-1 gene was amplified with the primers
E34 and E35 and cloned into the ClaI-NotI sites of the pagr-1::gfp
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(5.5Kb) plasmid. The pagr-1::gfp (8.6Kb) plasmid contains 5421 bp
of promoter region and the agr-1 genomic region covering the first
seven exons and introns (the primer E35 primes on the 59end of
exon 8). Furthermore, primer E34 was chosen downstream of the
putative signal sequence on exon1; the signal sequence is therefore
not present in the construct.
Pagr-1::gfp::agr-1 (p233). The gfp ORF was amplified from
pPD95.75 with the primers E36 and E37 and ligated into the ClaI
site of pagr-1::gfp (8.6Kb). A TAG stop codon terminates
translation at the end of the gfp ORF. Orientation and sequence
of the insert were checked. The gfp gene flanked by agr-1 sequences
was then excised from the plasmid with AflII and SgrAI, gel
purified, and co-injected (20 ng/ml) with the cosmid F09G5
(100 ng/ml).
Transgenic strains
The agr-1::reporter constructs were injected at a concentration of
50 ng/ml in wild type N2 animals or in dpy-20(e1282). As markers,
a plasmid containing a dpy-20+ genomic fragment (primers E42
and E43, plasmid p133) or pRF4 (rol-6(su1006)) were co-injected
at a final concentration of 10 ng/ml [95]. Integration of the
extrachromosomal arrays was induced by UV294 irradiation and
the integrated strains were then backcrossed 10 times in N2 to
remove unwanted mutations.
Agrin mutant strains
Three mutations in the agrin gene were isolated. The agr-1(eg1770)
and agr-1(eg153) mutants were created by Mos-driven mutagenesis
and were kindly provided by Dr. Jean-Louis Bessereau [96]. In the
agr-1(eg1770) mutant strain the Mos1 transposon was inserted into
the seventh exon (after the base pair at the position 4948,
according to the numbering in the cosmid T13C2) which brings
the transcript out of frame, therefore causing a strong loss of
function mutation. We tested whether alternative splicing could
result in the excision of the transposon and give rise to a functional
agrin transcript in the eg1770 mutants. In the cDNA from eg1770
worms we only found an agrin transcript containing the transposon
and no shorter forms, indicating that eg1770 is indeed a loss of
function mutant. The agr-1(eg153) agrin mutation was created by
transposon mobilization which led to an imprecise excision and
left an insertion of five base pairs (‘‘TGATA’’ at the position after
4948 of cosmid T13C2) from the agrin ORF and gave rise to
another putative out-of-frame mutation. The third mutant, agr-
1(tm2051), was kindly provided to us by the National BioResource
Project, the Japanese C. elegans knock-out consortium. The mutant
carries an in-frame deletion of 423 bp including exons 26 and 27
(nucleotides 22165-22587 of cosmid F41G3), which encode the
last laminin G domain and therefore disrupt a part of the gene
encoding potentially important sites of the protein [97].
Analysis of agrin mutants
Agrin mutants were analyzed for potential defects at the neuromus-
cular junction, by pharmacological treatments with aldicarb and
levamisole, following previously described procedures [47,71].
As AGR-1 is expressed in pharynx, we analysed worms for
related phenotypes, as described previously: pharyngeal pumping
rate, pharyngeal morphology [98], and worms’ feeding on large
bacteria [70].
Staining of amphid neurons
Amphid neurons were stained with 1,19-dioctadecyl-3,3,39,39-
tetramethylindocarbocyanine perchlorate (DiI, Invitrogen D-282)
[99]. Young adult hermaphrodites were incubated in M9, 5 mg/
ml DiI (with or without 50 mM CaAcetate) for two hours at room
temperature, washed three times in M9 and transferred to a NGM
plate with E. coli OP50. After two hours the worms were mounted
on agarose pads with 30 mM Na Azide [71] and analyzed with
a Zeiss LSM510 confocal microscope.
Cloning, expression and purification of agrin
fragments
Agrin cDNA coding for the first laminin G domain was amplified
with primers containing restriction sites: lam3 (SphI) and lam6
(HindIII) listed in Table 1. The 513 bp PCR product was digested
by SphI and HindIII restriction enzymes and cloned into the
pQE30 vector (Qiagen) containing a 6xHistidine (6xHis) tag just
upstream of the multiple cloning site. Expression and purification
were done following the QIAexpressionist protocol (Qiagen) under
denaturing conditions. The purified agrin fragment of 25kD was
analyzed by SDS-polyacrylamide gel electrophoresis (SDS PAGE)
and stained with Coomassie blue (GelCode, Pierce). Fractions of
the elution peak were pooled and dialysed against PBS2 for
further experiments.
The agrin fragment encoding both laminin G domains and the
C terminus of the protein, was amplified by specific primers,
named overlap59 and lam8euk4 (Table 1). The amplified agrin
fragment of 1203 bp was fused to an N-terminal fragment of
chicken tenascin-C containing a signal sequence and the epitope
for the monoclonal anti-tenascin-C (TNC) antibody anti-Tn60
[100]. The TNC fragment was amplified from pCTN 230 [101]
with T3 as the upstream primer and an antisense primer of which
the 39 half was homologous to the template sequence and the 59
part reverse complementary to the beginning of the agrin fragment
(primer agr/TN antisense, Table 1). The two fragments were
fused by PCR using the T3 and lam8euk4 primers. The resulting
fusion product of 2100 bp was digested with restriction enzymes
Cla I and Not I and cloned into pKSII. Insertion was verified by
sequencing and the fragment cloned into the Kpn I and Not I
restriction sites of the expression vector pCEP for expression in
HEK293EBNA cells. The cells were transfected with the
FugeneTM6 reagent (Roche) following the supplier’s protocol.
Since the recombinant agrin fragment contained the signal peptide
of vertebrate TNC, the protein product was secreted into the
conditioned medium which was then tested by western blotting
with anti-Tn60.
For large scale protein expression the cells were grown in 15cm
tissue culture dishes in DMEM/10%FCS until they reached 75%
confluency. Then the cells were washed with DMEM without FCS
and 24 to 48 hours after the medium change the conditioned
medium was collected. Agrin in the conditioned medium was
precipitated with 50% ammonium sulphate at 4uC. The pellet was
resuspended in PBS2/0.1% Tween and dialysed overnight against
the same buffer. Agrin was purified over an anti-Tn60 affinity
column as described previously for recombinant TNCs [101].
Elution fractions were analysed by SDS-PAGE and western
blotting. The fractions containing peak amounts of agrin fragment
were pooled and dialysed against PBS2. Alternatively, precipitated
conditioned medium was dialysed against PBS2 overnight and
DMEM for one hour to be used for in vitro binding assays with
dystroglycan (see below).
Monoclonal and polyclonal antibodies against C.
elegans agrin
The recombinant agrin fragment expressed in E. coli was used as
antigen for the immunization of mice to raise monoclonal
antibodies. Conditioned media from hybridoma clones were
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tested for antibody production and specificity. The activity was
determined by ELISA tests and western blots using recombinant
agrin protein encompassing both lamG domains expressed in
eukaryotic cells. Four hybridoma clones were positive, their
cultures were expanded, and the antibodies from conditioned
media concentrated over protein G columns. In further experi-
ments a pool of the purified monoclonal antibodies was used.
Polyclonal antibodies were raised in two rabbits (AG1 and AG2)
against the recombinant agrin fragment containing both lamG
domains fused to a short epitope of TNC. Antisera were tested by
western blot and immunofluorescence for the specificity to the
agrin fragment and preimmune sera, taken from the rabbits just
before the immunization, served as negative control. To purify
monospecific antibodies from these antisera the recombinant agrin
fragment used as antigen was bound to CNBr-activated Sephar-
oseTM 4B resin (Amersham Pharmacia) and packed into a column.
Polyclonal antiserum from rabbit AG1 was loaded, the column
was washed, bound antibodies eluted and their activity tested by
western blot of the recombinant protein. These highly purified
antibodies were used for the detection of endogenous agrin in C.
elegans.
Western blots
The purified agrin fragment of two lamG domains was run on
7.5% SDS PAGE [102] and transferred onto Immobilon
membrane (Millipore). The membrane was blocked for one hour
in 5% non-fat dry milk (Fluka) in TBS/Tween-20 (0.05%) (Fluka)
with gentle agitation at room temperature. Incubation with
primary antibodies was carried out overnight at 4uC slowly
rocking. The anti-agrin purified monoclonal antibody pool was
diluted 1:1000 and whole polyclonal antisera 1:8000 in blocking
solution (5% non-fat dry milk in TBS/Tween-20). The following
day membranes were washed over one hour with several changes
of TBS/Tween-20, followed by incubation with goat anti-mouse
or goat anti-rabbit horseradish peroxidase (HRP)-conjugated
secondary antibodies (Cappel, MP Biomedicals), diluted 1:2000
in 5% milk, during one hour at room temperature. After extensive
washing in TBS/Tween over more than one hour, protein on the
membrane was visualized by ECL reagent (Amersham Bios-
ciences) and exposed on Kodak Biomax MR film.
To detect endogenous worm agrin by western blotting young
larval stages were homogenized in ice-cold RIPA buffer (NaCl
150 mM, TrisHCl pH8 50 mM, NP-40 1%, deoxycholic acid
0.5%, SDS 0.1%, NaF 50mM) containing a cocktail of protease
inhibitiors (Complete Mini EDTA-free, Roche). The suspension
was centrifuged for 30 minutes at 14000 rpm in a tabletop
centrifuge at 4uC. The supernatant was kept and the pellet
resuspended in RIPA buffer including 6M urea and centrifuged
for additional 30 min at RT. The supernatant was separated and
the pellet resuspended in reducing sample buffer (SB+) with 6M
urea. All fractions were heated for 5 minutes at 95uC and run on
a 6% SDS PAGE, followed by western blotting, as described
above. Purified polyclonal antibodies (AG1) were diluted 1:500 in
the blocking solution and anti-rabbit secondary antibody 1:10000.
Immunoreactive proteins were visualized by the HRP substrate
Super Signal (Pierce) exposed to double-coated ML film (Kodak)
for 1 minute.
Immunofluorescence
COS cells were grown in 35mm tissue culture dishes and
transfected with pCEP-Agrin using Fugene 6 reagent (Roche).
24 hours after transfection the cells were rinsed with PBS+ and
fixed with 4% PFA in PBS2 for 15 minutes at room temperature.
Cells were permeabilized with 0,1% TritonX-100 (Fluka) in PBS2
during 5 minutes at room temperature. After rinsing with PBS2,
the cells were blocked with 3% goat serum in PBS2 during
15 minutes at room temperature. Primary antibodies were diluted
1:100 in blocking solution and incubated 2 hours at room
temperature. After washing in PBS2, the secondary antibody
was diluted 1:1000 in blocking solution and incubated on cells for
one hour at room temperature in the dark. Goat anti-mouse and
goat anti-rabbit FITC antibodies (Alexa 488, Molecular Probes)
were used on separate samples of cells. Together with the
secondary antibodies, Hoechst dye (Fluka) was added at dilution
1:1000 for visualization of cell nuclei. Cells were washed with
PBS2, rinsed with deionized water to remove traces of salt, and
mounted with ProLong Gold antifade reagent (Invitrogen). The
pictures were obtained on a Zeiss Z1 upright fluorescence
micoscope for multi-dimensional acquisition. The same conditions
were used for all the samples, 1006 magnification, exposure of
500 ms for FITC and 80 ms for Hoechst.
To simultaneously stain for agrin and endogenous b-dystrogly-
can in COS cells, cells were treated as described above. The anti-
agrin polyclonal antiserum was used at 1:100 dilution and the
monoclonal anti- b-dystroglycan antibody 43DAG1/8D5 (Novo-
castra, kindly provided to us by Prof. Markus Ru¨egg) at 1:100
dilution in blocking solution. The b-dystroglycan antibody was
visualized by a goat anti-rabbit secondary antibody coupled with
a red dye (Alexa FluorH 594, Molecular Probes) and anti-agrin by
green-labelled goat anti-mouse (Alexa FluorH 488, Molecular
Probes).
Immunofluorescence staining of endogenous worm
agrin
Worms were immunostained following a modified Finney&R-
uvkun protocol [103]. Mixed stages of worms, grown on NGM
plates, were extensively washed in M9 buffer. The last wash was
done with deionised water and the worms were quick-frozen on
dry ice/ethanol in Ruvkun fixation buffer mix diluted from a 26
stock (160 mM KCl, 40 mM NaCl, 20 mM Na2EGTA, 10mM
spermidine-HCl, 30mM Pipes, pH 7.4, and 50% methanol) with
the addition of 1.5% formaldehyde. Following permeabilization by
freeze-thaw in three cycles, worms were fixed for 1 hour on ice.
The cuticle reduction and final permeabilisation was done by TTB
and 1% b-mercaptoethanol overnight, slowly rotating at 37uC.
Permeabilization was completed the following day by 10mM
dithiothreitol (DTT) in 16 BO3 buffer (diluted from 206 stock:
1M H3BO3, 0.5M NaOH), including 0.01% Triton and 0.3%
H2O2 in the same buffer for additional 15 minutes. The worms
were blocked in AbB buffer (16PBS, 0.1% BSA, 0.5% TritonX-
100, 0.05% Na-azide, and 1mM EDTA) and immunostained with
the antibody solution in the AbA buffer (1% BSA) overnight at
4uC with gentle rocking. The mouse monoclonal anti-agrin
antibody pool used at 1:200 dilution, the rabbit polyclonal anti-
agrin antibody at 1:100, and a rabbit polyclonal anti-rim antibody
1:6000 [69]. The anti-rim was kindly provided by Prof. Michael
Nonet. Worms were washed with AbB during several hours and
incubated with the secondary antibody at 1:1000 dilution in AbA
buffer at room temperature gently rocking in the dark during two
hours. For agrin monoclonal antibodies anti-mouse secondary
antibody conjugated with a green dye (Alexa FluorH 488,
Molecular Probes), for polyclonal anti-agrin secondary anti-rabbit
labeled green (Alexa FluorH 488, Molecular Probes) and for rim
polyclonal antibody red-labeled anti-rabbit (Alexa FluorH 546,
Molecular Probes) was used. Following extensive washing in AbB
during two hours, the worms were mounted on glass slides with
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Mowiol (Dabco) mounting medium. Images of agrin/rim co-
staining were obtained by a confocal LSM510 META Axioplan2
microscope and for single agrin stainings by the polyclonal
antibody a Zeiss Axioscope Bio microscope was used.
In vitro assay for agrin-b-dystroglycan binding
Purified chicken a-dystroglycan ([104]; kind gift from Prof. Markus
Ru¨egg) was run on 7.5% SDS PAGE (2.5 mg protein per lane) and
transferred to a nitrocellulose membrane. The membrane was
blocked for two hours in blocking buffer (PBS, 0.05% Tween-20,
1mM CaCl2, 1mM MgCl2, 5% milk). The membrane was cut in
strips which were incubated with different samples of agrin.
Chicken recombinant agrin proteins were kindly provided by Prof.
M. Ru¨egg [97]. The chicken agrin fragments were 120 kDa in
size, containing 25 kDa of N-terminal laminin-binding domain
(NtA) fused to all three C-terminal lam G domains of 95 kDa,
differing only in the alternative splicing essential for dystroglycan
binding [21]. The fragment of a splice variant of chicken agrin
enriched in muscles was used as positive control for DG binding,
the chicken agrin neural isoform as negative control, and C. elegans
recombinant fragment containing two lamG domains was tested.
Final concentration of both agrin control samples was 4 mg/ml.
The incubation was carried out overnight at 4uC with gentle
agitation. The following day, membrane strips were washed in
blocking buffer (5% milk in TBS/Tween-20). Detection of bound
agrin fragments was performed as described for western blotting
with minor modifications. The polyclonal anti-chick agrin
antibodies were prepared by Dr. Shuo Lin and kindly provided
to us by Prof. Markus Ru¨egg. Incubation with the primary
antibodies was done during 3 hours at room temperature.
Polyclonal anti-chicken agrin antibody was diluted 1:2000 in 5%
milk blocking solution. The C. elegans agrin fragment was detected
by anti-Tn60 [100] diluted 1:1000 in 3% BSA blocking solution.
Following washing in 5% milk blocking solution, membrane strips
were incubated with HRP-conjugated goat anti-mouse antibody
diluted 1:2000, during one hour at room temperature. After
extensive washing in TBS/Tween proteins were visualized by
ECL reagent (Amersham Pharmacia) and the membranes exposed
to Kodak BioMax MR film.
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